Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
EClinicalMedicine
; 39: 101086, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34405140
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
EClinicalMedicine
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: